Let’s explore “kidney disease”

PURSER WELLNESSBreast Cancer Awareness - Part 1From the reading room

…volving ideas. However, too many are still affected by this disease which is why treatment and prevention must continue to improve. I am fortunate to survive my fight with breast cancer, but I have friends and family who fought until the ve…

PURSER WELLNESSGMO vs non-GMOFrom the reading room

…to the goals of reducing hunger, poverty, malnutrition, and disease. On the contrary, GMOs divert money and resources that could be spent on safer, reliable, and appropriate technologies. 10. Reduce demand for GMOs and increasing overall co…

PURSER WELLNESSGENOVA™ Neopterin Biopterin Urine Profile for MTHFRFrom the reading room

…ious, inflammatory, immune system dysfunction or neoplastic disease evolution. Excessive neopterin negatively impacts the Nitric Oxide pathway in the body (e.g. excessive peroxynitrite formation and oxidative stress). Neopterin is a useful …

…mechanism is an explanation for how it might participate in disease. An outcome is what happens to a person, such as having a stroke. Finding an association between a marker and an outcome does not show that changing the marker changes the …

…teine. The source considers nutrition, inherited variation, kidney function, medicines and lifestyle rather than treating a result as a stand-alone explanation for symptoms. Two routes through one metabolic junction The chapter describes h…

…ated Homocysteine Levels on Cardiovascular, Cerebrovascular Disease, and Mortality Homocysteine and cardiovascular risk The idea to explore A guide to the chapter’s discussion of homocysteine, vascular injury and cardiovascular or cerebro…

…nt verification of patent status, comparative absorption or disease-treatment claims. Patent discussion alone is not clinical evidence of benefit. A question for your next conversation Which of the three questions does the evidence actuall…

…es not tell you by itself how much is absorbed or whether a disease outcome improves. Read the author’s formulation discussion as an explanation of the proposed design. Then look separately for measurements of composition, stability and cli…

…nt verification of patent status, comparative absorption or disease-treatment claims. Patent discussion alone is not clinical evidence of benefit. A question for your next conversation What was measured after application: a skin effect, ab…

…, the drug known as Skyrizi, in the context of inflammatory disease and then extends the discussion to a proposed homocysteine connection. Its own introduction acknowledges the lack of direct trials evaluating homocysteine regulation. A pr…

…ment that improves a symptom does not automatically prevent disease. A hormone measurement also needs a reason for being checked. Reading with a clear goal makes it easier to compare the author’s approach with the choices discussed in an in…

…cofactors, essential oils, Hashimoto’s thyroiditis, Graves’ disease, reverse T3 and adverse effects. The source’s emphasis is on connecting symptoms to a fuller conversation about thyroid testing. Its individualized stories and dosing sugge…